Canada’s medical cannabis market plateauing after recreational legalization – at least for now
The number of active medical marijuana patients in Canada appears to have leveled off about a year after adult-use cannabis was legalized […]
Category: Aphria
Cannabis company Aphria reports quarterly EBITDA growth, net loss in Q4
Major Canadian cannabis producer Aphria on Wednesday reported strong quarterly EBITDA growth, despite coronavirus-related impairment charges from its international operations that contributed […]
Aleafia, Aphria settle dispute over supply deal for CA$29.1 million
Canadian cannabis producers Aleafia Health and Aphria have settled a dispute over a supply deal gone wrong. In 2018, Emblem Cannabis signed […]
Canada’s discount cannabis segment heats up with competing value brands
High prices were a regular consumer complaint when Canada legalized recreational cannabis in October 2018. Only a year and a half later, […]
As marijuana class action lawsuits surge, experts stress accurate, forthright disclosures
Class action lawsuits against cannabis companies are rising, driven by industry growth, stock price volatility, regulatory uncertainties and preventable mistakes by the […]
Ontario Cannabis Store report shows Aurora leading flower sales, COVID-19 sales boost
New data released by the Ontario Cannabis Store (OCS) reveals key details about marijuana sales and consumer preferences in Canada’s largest province, […]
Cannabis producer Aphria moving US listing to Nasdaq from NYSE
Canadian cannabis cultivator Aphria is moving its U.S. stock listing to a new venue, departing the New York Stock Exchange (NYSE) in […]
Cannabis firm Green Growth Brands gets initial creditor protection
Ohio-based marijuana retailer Green Growth Brands said Wednesday it has filed for insolvency protection in Canada. The financially troubled multistate operator – […]